logo
New Bentonville medical school welcomes first students

New Bentonville medical school welcomes first students

Axios21-07-2025
The Alice L. Walton School of Medicine's inaugural class of 48 students began medical school this month in a new building designed with the school's "whole health" philosophy in mind.
The big picture: The four-year medical school founded and funded by Walmart heir Alice Walton seeks to train future doctors in traditional medicine, but with an emphasis on holistic and preventive care involving mental, emotional and social health, nutrition and exercise.
The school also intends to emphasize humanities concepts like communication so students learn to listen to and communicate with their patients, dean and CEO Sharmila Makhija previously told Axios.
Driving the news: Wesley Walls of Polk Stanley Wilcox Architects and Simon David of New York-based Office of Strategy and Design, which provided landscape architecture services, gave a tour Friday of part of the building and its surrounding outdoor amenities on J Street in Bentonville.
The intrigue: The four-story, 154,000-square-foot building is designed to incorporate nature and wellness. It features sandstone, lots of large windows, several outdoor spaces where students can spend time together, a garden and surrounding trails.
A café with indoor and outdoor seating is open to students and will also open to the public in November. A trail connects the school to Walton's Crystal Bridges Museum of American Art.
There's also space throughout the interior where artwork can be displayed.
By the numbers: The school received more than 2,000 applications, spokesperson Wendy Echeverria told Axios. Less than 3% of applicants were accepted.
A third of the class is from Arkansas, while the rest are from 18 other states. These students and the next four cohorts after them will receive free tuition, the school announced in October.
More than 50 faculty members work at the school.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Walmart Frozen Shrimp Subject To Recall Due To Potential Radioactive Risks
The Walmart Frozen Shrimp Subject To Recall Due To Potential Radioactive Risks

Yahoo

timean hour ago

  • Yahoo

The Walmart Frozen Shrimp Subject To Recall Due To Potential Radioactive Risks

The Food and Drug Administration (FDA) has protocols in place to detect contaminated foods before they enter the country. And, as of today, it has advised the public not to eat specific Great Value brand frozen raw shrimp sold in Walmart stores due to a possible radioactive risk. During regular inspections, the U.S. Customs & Border Protection (CBP) detected Cesium-137 (Cs-137) in a single sample of breaded shrimp, and all related containers and products were prevented from entering the United States. Cs-137 is a manmade radioisotope of cesium that's so widespread that it can be found in the air, soil, and food. After the FDA was alerted to the presence of this chemical, its own testing found about 68.48 Bq/kg — much lower than the 1200 Bq/kg threshold — in the breaded product (per the FDA advisory). Although the chemical wasn't found in other products tested, the agency says some could still be contaminated, representing a potential health concern but not an acute hazard. Since the investigation is ongoing, it's unclear if this frozen shrimp will become one of the worst seafood recalls that swept across America or even be among the biggest Walmart Great Value brand recalls in history. Read more: 14 Canned Foods To Stock Up On Before They Go Up In Price Specific Products Affected And What To Do The convenience and versatility of frozen shrimp make it a staple for many households. When you're looking for high-quality frozen shrimp to buy, though, reading the package label and looking for quality characteristics won't always protect you when some kind of contamination has occurred. The 2-pound bags of Great Value Raw Ez Peel Tail-On Farm-Raised White Vannamei Shrimp that the FDA is concerned about are processed by PT. Bahari Makmur Sejati, an Indonesian company that does business as BMS Foods. The lot codes are 8005540-1, 8005538-1, and 8005539-1 — all with a Best by Date of March 15, 2027. Exposure to possible low-level radiation from Cs-137 in these products could impact consumers' health with prolonged exposure. Because of that, the FDA suggests that customers who have purchased any of these packages throw them away; do not eat or serve them. It also advises that customers contact their healthcare teams if they have already eaten these products and experience adverse symptoms. Meanwhile, the FDA has recommended that Walmart issue a recall and that all distributors and retailers not sell or serve the products. Hungry for more? Sign up for the free Daily Meal newsletter for delicious recipes, cooking tips, kitchen hacks, and more, delivered straight to your inbox. Read the original article on The Daily Meal. Solve the daily Crossword

Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection
Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection

Business Upturn

time2 hours ago

  • Business Upturn

Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection

Dr. Lal PathLabs has taken a groundbreaking step in advancing cancer diagnostics in India by becoming the first laboratory in the country to introduce a deep learning-based AI module for the detection of lymph node metastasis, including micrometastasis. This innovation, developed in collaboration with Singapore-based healthtech company Qritive, was recently showcased at USCAP 2025, one of the most prestigious pathology conferences in the world. The accurate detection of cancer spread to lymph nodes is a critical factor in determining the stage and treatment strategy for patients. Missing these signs of cancer progression can allow the disease to advance, increasing the chances of it spreading to distant organs and reducing survival rates. The ability to identify even occult metastases in patients with early-stage cancer has the potential to significantly influence treatment plans and improve outcomes. Traditionally, detecting micrometastases—small clusters of cancer cells hidden in lymph nodes—has been a time-consuming and complex process, often requiring advanced testing. The new AI system, called QiAI Lymph Node Dx, addresses this challenge by using deep learning to analyze digital slides and identify cancer cells with exceptional precision. This integration of AI into diagnostic practice ensures that cancer detection becomes faster, more reliable, and highly accurate. What makes this development especially impactful is its ability to pick up even single cancer cells, which were later validated through immunohistochemistry testing. The AI model has been tested across various cancer types, including breast, colon, stomach, and esophageal cancers, consistently delivering highly accurate results. Breast cancer, which accounts for nearly 28% of cancer cases among women in India, particularly stands to benefit from this breakthrough, highlighting the clinical relevance of the technology. By achieving complete sensitivity and negative predictive value—meaning no metastatic cases went undetected—the AI system has proven to be a robust screening tool. Its tumor-agnostic design allows it to function effectively across different cancer types, making it a versatile solution for oncologists and pathologists alike. As cancer incidence continues to rise in India, the integration of advanced AI-powered diagnostic tools such as QiAI Lymph Node Dx is set to transform the landscape of cancer care. By enabling earlier and more accurate diagnoses, this technology not only improves the efficiency of medical practice but also ensures better treatment decisions, offering renewed hope to patients battling cancer. Ahmedabad Plane Crash

FDA Warns Against Eating Shrimp Brand, Citing Radioactive Matter
FDA Warns Against Eating Shrimp Brand, Citing Radioactive Matter

Bloomberg

time3 hours ago

  • Bloomberg

FDA Warns Against Eating Shrimp Brand, Citing Radioactive Matter

The US Food and Drug Administration has advised the public not to eat a brand of shrimp sold at Walmart Inc. over concerns about radioactive contamination. The agency told Walmart to pull three lots of raw frozen shrimp sourced from Indonesia after officials detected radioactive Cesium-137 in a shipment that did not enter the US, the FDA said in a statement on Tuesday. The isotope can lead to an elevated risk of cancer through repeated exposure to low doses, though the detected levels were not high enough to cause an acute risk, the FDA said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store